CCOR icon

Core Alternative Capital

27.03 USD
-0.06
0.22%
Updated Jun 16, 12:48 PM EDT
1 day
-0.22%
5 days
0.04%
1 month
-1.74%
3 months
0.45%
6 months
5.34%
Year to date
5.83%
1 year
7.90%
5 years
-4.82%
10 years
7.56%
0
Funds holding %
of 7,297 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

11.39% less ownership

Funds ownership: 70.81% [Q4 2024] → 59.43% (-11.39%) [Q1 2025]

21% less funds holding

Funds holding: 34 [Q4 2024] → 27 (-7) [Q1 2025]

46% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 13

48% less capital invested

Capital invested by funds: $74M [Q4 2024] → $38.1M (-$35.9M) [Q1 2025]

78% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 9

Research analyst outlook

We haven’t received any recent analyst ratings for CCOR.

Financial journalist opinion

Neutral
Seeking Alpha
1 month ago
CCOR: Look At HELO Instead
The Core Alternative ETF holds 42 stocks with expected earnings and dividend growth, combined with options for downside protection. Despite outperforming the benchmark over the last 6 months, the historical return of CCOR is disappointing. HELO offers better returns, lower volatility, cheaper fees, and higher liquidity, making it a more compelling choice for downside protection strategies.
CCOR: Look At HELO Instead
Positive
Zacks Investment Research
2 months ago
Large-Cap Blend ETF (CCOR) Hit a New 52-Week High
For investors seeking momentum, Core Alternative ETF CCOR is probably on the radar. The fund just hit a 52-week high and is up 13.9% from its 52-week low price of $24.69/share.
Large-Cap Blend ETF (CCOR) Hit a New 52-Week High
Neutral
Zacks Investment Research
3 months ago
5 Defensive ETF Strategies to Follow Amid Market Meltdown
We highlight some defensive investment strategies for investors amid the ongoing chaos.
5 Defensive ETF Strategies to Follow Amid Market Meltdown
Neutral
Zacks Investment Research
3 months ago
The Zacks Analyst Blog CCOR, BALT, XRMI, PHDG and HEQT
CCOR, BALT, XRMI, PHDG and HEQT are included in this Analyst Blog.
The Zacks Analyst Blog CCOR, BALT, XRMI, PHDG and HEQT
Negative
Zacks Investment Research
3 months ago
Low-Beta ETFs to Hedge Against Trade War Risks
Investors seeking to remain invested in the equity world with downside protection should invest in low-beta ETFs.
Low-Beta ETFs to Hedge Against Trade War Risks
Neutral
Zacks Investment Research
9 months ago
5 ETF Strategies to Survive a Historically Weak September
Wall Street falters at the start of September. The weak trend is likely to continue, given that September is one of the market's historically worst months.
5 ETF Strategies to Survive a Historically Weak September
Negative
Zacks Investment Research
9 months ago
More Volatility Ahead? ETF Strategies to Play
August has been a turbulent month for financial markets. Some strategists believe that volatility may continue in the coming days if the U.S. economic data points come in at unstable.
More Volatility Ahead? ETF Strategies to Play
Neutral
Zacks Investment Research
10 months ago
5 ETF Strategies to Follow Amid the Current Market Turmoil
A defensive investment minimizes risk and protects your portfolio during market downturns. It involves investing in stable, low-volatility stocks that have a history of consistent performance, even during economic downturns.
5 ETF Strategies to Follow Amid the Current Market Turmoil
Negative
Zacks Investment Research
10 months ago
Low-Beta ETFs to Buy Amid Market Turmoil
Investors may remain invested in the equity world with some downside protection by investing in low-beta ETFs.
Low-Beta ETFs to Buy Amid Market Turmoil
Positive
Zacks Investment Research
1 year ago
5 Niche ETFs That Outperformed Last Week
Wall Street had a tumultuous last week on growing inflation fears and rising geopolitical tensions. While most of the segments suffered losses last week, a few niche corners have performed really well.
Charts implemented using Lightweight Charts™